IP Library Granted Patent US 7,662,566
Granted Patent B2
US 7,662,566 · App. 11/944,269 · Granted Feb 16, 2010

Gene copy number profiling

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,662,566
App. No.
11/944,269
Granted
Feb 16, 2010
Kind
B2
Abstract

The invention relates to copy number profile analysis. Specifically, copy number profile analysis is used to determine whether two or more separate tumors in a single individual are derived from a common source.

Claims (33)

1. A method of determining whether two separate tumor samples are derived from the same source, comprising:

providing a first copy number profile from a first tumor sample obtained from a patient, said first copy number profile comprising copy number information for a plurality of genomic loci;

providing a second copy number profile from a second tumor sample obtained from said patient, said second copy number profile comprising copy number information for said plurality of genomic loci;

comparing said first copy number profile and said second copy number profile;

wherein if said first copy number profile is substantially similar to said second copy number profile, it indicates said first tumor sample and said second tumor sample are from the same source; and

wherein if said first copy number profile is substantially different from said second copy number profile, it indicates said first tumor sample and said second tumor sample are from different sources.

2. The method of claim 1 wherein said first tumor sample is an ovarian tumor sample and wherein said second tumor sample is an endometrial tumor sample.

3. A method of determining whether two separate tumor samples are derived from the same source, comprising:

providing a first copy number profile from a first tumor sample obtained from a patient, said first copy number profile comprising copy number information for a plurality of genomic loci at a resolution of at least 500 Kb;

providing a second copy number profile from a second tumor sample obtained from said patient, said second copy number profile comprising copy number information for said plurality of genomic loci at a resolution of at least 500 Kb;

comparing said first copy number profile and said second copy number profile;

wherein if said first copy number profile is substantially similar to said second copy number profile, it indicates said first tumor sample and said second tumor sample are from the same source; and

wherein if said first copy number profile is substantially different from said second copy number profile, it indicates said first tumor sample and said second tumor sample are from different sources.

4. A method of determining whether two separate tumor samples are derived from the same source, comprising:

providing a first copy number profile from a first tumor sample obtained from a patient, said first copy number profile comprising copy number information for a plurality of genomic loci;

providing a second copy number profile from a second tumor sample obtained from said patient, said second copy number profile comprising copy number information for said plurality of genomic loci;

providing a comparison between said first copy number profile and said second copy number profile;

wherein if said first copy number profile is substantially similar to said second copy number profile, it indicates said first tumor sample and said second tumor sample are from the same source; and

wherein if said first copy number profile is substantially different from said second copy number profile, it indicates said first tumor sample and said second tumor sample are from different sources.

5. A method of determining whether two separate tumor samples are derived from the same source, comprising:

providing a first copy number profile from a first tumor sample obtained from a patient, said first copy number profile comprising copy number information for a plurality of genomic loci;

providing a second copy number profile from a second tumor sample obtained from said patient, said second copy number profile comprising copy number information for said plurality of genomic loci;

comparing said first copy number profile and said second copy number profile;

communicating the results of said comparing step to a third party;

wherein if said first copy number profile is substantially similar to said second copy number profile, said third party concludes said first tumor sample and said second tumor sample are from the same source; and

wherein if said first copy number profile is substantially different from said second copy number profile, said third party concludes said first tumor sample and said second tumor sample are from different sources.

6. A method of determining whether two separate tumor samples are derived from the same source, comprising:

determining a first copy number profile from a first tumor sample obtained from a patient by measuring copy number information for a plurality of genomic loci;

determining a second copy number profile from a second tumor sample obtained from said patient by measuring copy number information for said plurality of genomic loci;

comparing said first copy number profile and said second copy number profile;

wherein if said first copy number profile is substantially similar to said second copy number profile, it indicates said first tumor sample and said second tumor sample are from the same source; and

wherein if said first copy number profile is substantially different from said second copy number profile, it indicates said first tumor sample and said second tumor sample are from different sources.

7. The method of claim 6 , further comprising displaying said first and second copy number profiles on an electronic display.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Jul 10, 2023
From: JPMORGAN CHASE BANK, N.A.
To: MYRIAD GENETICS, INC.; CRESCENDO BIOSCENCE, INC.; MYRIAD RBM, INC.; MYRIAD WOMEN'S HEALTH, INC.
Reel/Frame 064239/0091 →
SECURITY INTEREST Recorded Dec 27, 2016
From: MYRIAD GENETICS, INC.
To: JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT
Reel/Frame 041198/0578 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 12, 2012
From: ELISHAEV, ESTHER
To: UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION
Reel/Frame 028537/0666 →